Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Drug Resistance

Free Subscription 01.12.2025 1 AIDS 1 Antimicrob Agents Chemother 8 Int J Antimicrob Agents 10 J Antimicrob Chemother 1 J Clin Microbiol 2 J Med Microbiol 1 PLoS One 3 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. CALCAGNO A, Carola L, Barbara R, Marco M, et al
   Full reservoirs and poor adherence: two cases of symptomatic HIV cerebrospinal fluid escape with tenofovir alafenamide/emtricitabine/bictegravir.
   AIDS. 2025 Aug 8. doi: 10.1097/QAD.0000000000004320.
   PubMed         Abstract available
   
   

   
   Antimicrob Agents Chemother

2. FUNK OG, Li J, Khan I, Cusumano JA, et al
   Ceftobiprole alone versus ampicillin-ceftriaxone against borderline-penicillin-resistant, ampicillin-susceptible, and vancomycin-resistant Enterococcus faecalis isolates.
   Antimicrob Agents Chemother. 2025 Nov 24:e0105025. doi: 10.1128/aac.01050.
   PubMed         Abstract available
   
   

   
   Int J Antimicrob Agents

3. QUAN J, Zhou M, Liao W, Hu H, et al
   Enhancement of virulence related to polymyxin resistance caused by CrrB mutation in a hypervirulent KPC-2-producing Klebsiella pneumoniae belonging to KL2-ST65 clone.
   Int J Antimicrob Agents. 2025;66:107641.
   PubMed         Abstract available
   
   
4. LV X, Ye F, Pan J, Hu P, et al
   Expanded applications of omeprazole: Synergistic reversal of colistin resistance in Acinetobacter baumannii.
   Int J Antimicrob Agents. 2025;66:107639.
   PubMed         Abstract available
   
   
5. GUO T, Ding L, Shen S, Tang C, et al
   Molecular characterisation of two novel KPC variants mediating ceftazidime-avibactam resistance in ST11 Klebsiella pneumoniae.
   Int J Antimicrob Agents. 2025;66:107642.
   PubMed         Abstract available
   
   
6. FAROOQ A, Nang SC, Yu HH, Wickremasinghe H, et al
   A pharmacometric model assessing the in vitro synergistic effect of a bacteriophage-polymyxin B combination in a clinical multidrug-resistant Klebsiella pneumoniae isolate.
   Int J Antimicrob Agents. 2025;66:107628.
   PubMed         Abstract available
   
   
7. HSUEH SC, Chen CL, Lin CR, Lin HH, et al
   Evaluation of the Roche cobas MTB and MTB-RIF/INH for detecting Mycobacterium tuberculosis complex and resistance to isoniazid and rifampicin: A prospective, multicenter diagnostic accuracy study.
   Int J Antimicrob Agents. 2025;66:107605.
   PubMed         Abstract available
   
   
8. PENG Z, Wang J, Kang S, Xu S, et al
   A single amino acid in PBP1a drives high-level penicillin and amoxicillin resistance in streptococcus suis.
   Int J Antimicrob Agents. 2025;66:107604.
   PubMed         Abstract available
   
   
9. WANG B, Fu J, He Y, Li K, et al
   Molecular epidemiology and genomic insights into Enterobacter cloacae complex co-harbouring bla(KPC) and mcr: Implications for resistance gene transmission.
   Int J Antimicrob Agents. 2025;66:107602.
   PubMed         Abstract available
   
   
10. LIU S, Fang L, Zhu W, Xu H, et al
    Emergence of a novel transferable megaplasmid driving bla(VIM-24) and tmexCD3-toprJ3 dissemination in clinical Pseudomonas fulva isolates.
    Int J Antimicrob Agents. 2025;66:107594.
    PubMed         Abstract available
    
    

    
    J Antimicrob Chemother

11. JOHNSON A, Madec JY, Pournaras S
    JAC Supplement: Survey of Antibiotic Resistance (SOAR) results 4-respiratory pathogen susceptibility.
    J Antimicrob Chemother. 2025;80.
    PubMed        
    
    
12. MIN P, Yao J, Ruan S, Zhou L, et al
    Global phylogeography and genomic characterization of blaNDM-1-positive carbapenem-resistant Acinetobacter soli.
    J Antimicrob Chemother. 2025 Nov 24:dkaf437. doi: 10.1093.
    PubMed         Abstract available
    
    
13. TORUMKUNEY D, Canton R, Pitart C, Sanguinetti M, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2018-21 in Italy and Spain: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
    J Antimicrob Chemother. 2025;80.
    PubMed         Abstract available
    
    
14. TORUMKUNEY D, Nizamuddin S, Morrissey I, Manenzhe R, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2018-21 in Pakistan: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
    J Antimicrob Chemother. 2025;80.
    PubMed         Abstract available
    
    
15. TORUMKUNEY D, Bratus E, Yuvko O, Pertseva T, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2018-21 in Ukraine: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
    J Antimicrob Chemother. 2025;80.
    PubMed         Abstract available
    
    
16. TORUMKUNEY D, Slim L, Hammami A, Hawser S, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2018-21 in Tunisia: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
    J Antimicrob Chemother. 2025;80.
    PubMed         Abstract available
    
    
17. TORUMKUNEY D, Keles N, Hasdemir U, Hazirolan G, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2018-21 in Turkiye: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
    J Antimicrob Chemother. 2025;80.
    PubMed         Abstract available
    
    
18. TORUMKUNEY D, Veeraraghavan B, Patil N, Dias M, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2018-21 in India: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
    J Antimicrob Chemother. 2025;80.
    PubMed         Abstract available
    
    
19. TORUMKUNEY D, Van PH, Thinh LQ, Hawser S, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2020-21 in Vietnam: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
    J Antimicrob Chemother. 2025;80.
    PubMed         Abstract available
    
    
20. TORUMKUNEY D, Mokaddas E, Weber S, Morrissey I, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2018-21 in Kuwait and the United Arab Emirates: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
    J Antimicrob Chemother. 2025;80.
    PubMed         Abstract available
    
    

    
    J Clin Microbiol

21. WIESMANN N, Enders D, Westendorf A, Koch R, et al
    Prediction of antimicrobial resistance from MALDI-TOF mass spectra using machine learning: a validation study.
    J Clin Microbiol. 2025 Nov 26:e0118625. doi: 10.1128/jcm.01186.
    PubMed         Abstract available
    
    

    
    J Med Microbiol

22. ALWASHAISH MM
    Clinical outcomes and risk factors associated with bloodstream infections caused by multidrug-resistant Gram-negative bacteria in hospitalized patients: a prospective cohort study in Libya.
    J Med Microbiol. 2025;74:002101.
    PubMed         Abstract available
    
    
23. PAWAR K, Singh A
    Mechanism of azole resistance in Candida glabrata isolates from India: clinical vs. induced perspectives.
    J Med Microbiol. 2025;74:002083.
    PubMed         Abstract available
    
    

    
    PLoS One

24. LIAO J, Cheng J, Liu B, Shao Y, et al
    Disruption of yqhG attenuates virulence in methicillin-resistant Staphylococcus aureus by compromising membrane stability and oxidative stress resistance.
    PLoS One. 2025;20:e0337292.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

25. TRAN PM, Anaya-Sanchez A, Ji DX, Schwarz MCR, et al
    Cell envelope maintenance by PhoP is essential for Mycobacterium tuberculosis methylglyoxal resistance.
    Proc Natl Acad Sci U S A. 2025;122:e2523024122.
    PubMed         Abstract available
    
    
26. ANGELES-SOLANO M, Tabashsum Z, Liu JD, Lifschin ZJ, et al
    Antibiotics accumulate in Klebsiella pneumoniae liver abscesses but fail to eliminate antibiotic-tolerant populations.
    Proc Natl Acad Sci U S A. 2025;122:e2524436122.
    PubMed         Abstract available
    
    
27. SCHINDL A, Jones ME, Ghimire L, Kalverda AP, et al
    Inhibition of fusidic acid resistance through restricting conformational flexibility in domain III of EF-G.
    Proc Natl Acad Sci U S A. 2025;122:e2508779122.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Drug Resistance is free of charge.